Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 AUD | 0.00% | +20.00% | +9.09% |
05-24 | PYC Therapeutics Secures US FDA Orphan Drug Designation for Eye Disease Medication Candidate; Shares Fall 4% | MT |
05-16 | PYC Therapeutics Completes Dosing for Eye Disease Trial; Shares Fall 5% | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.09% | 371M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- PYC Stock
- News PYC Therapeutics Limited
- Transcript : PYC Therapeutics Limited - Special Call